Safety of endoscopy in patients with end-stage liver disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 11, Issue 1, 2001, Pages 111-130

  McGuire, B M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; CLINDAMYCIN; DESMOPRESSIN; DIAZEPAM; DROPERIDOL; FENTANYL; FLUMAZENIL; FRESH FROZEN PLASMA; MIDAZOLAM; NALOXONE; NEUROLEPTIC AGENT; OCTREOTIDE; OPIATE; OPIATE ANTAGONIST; PETHIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEDATIVE AGENT; VITAMIN K GROUP;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENDOSCOPIC BIOPSY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SPHINCTEROTOMY; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTENSION; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; OXYGEN SATURATION; PATIENT MONITORING; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; REVIEW; SEDATION; VEIN LIGATION;

EID: 0035141670     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1052-5157(18)30090-4     Document Type: Review

References (81)

1. Pulse oximetry: Utility in detecting arterial hypoxemia in subjects with cirrhosis
2. Practice guidelines for sedation and analgesia by non-anesthesiologists
3. Results from the American Society of Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy
4. Guideline on the management of anticoagulation antiplatelet therapy for endoscopic procedures
5. Role of PEG/PEJ in enteral feeding
6. Sedation and monitoring of patients undergoing gastrointestinal endoscopic procedures
7. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis
8. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
9. Sclerotherapy with or without octreotide for acute variceal bleeding
10. Platelet function defects associated with hemorrhage or thrombosis
11. Systemic antibiotic therapy prevents bacterial infections in cirrhotic patients with gastrointestinal hemorrhage
12. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal hemorrhage
13. Portal hypertension
14. Bacteremia with gastrointestinal endoscopic procedures
15. Desmopressin and bleeding time in patients with cirrhosis
16. Indications and contraindications for upper gastrointestinal endoscopy
17. The use of pulse oximetry during conscious sedation
18. Platelet function in liver disease
19. Prevention of bacterial endocarditis: Recommendations by the American Heart Association
20. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis
21. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis
22. Use of DDAVP in inherited and acquired platelet dysfunction
23. Fatal and disastrous complications following percutaneous endoscopic gastrostomy
24. Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: Its cause and consequences
25. Carbon dioxide retention and oxygen desaturation during gastrointestinal endoscopy
26. Complications of endoscopic biliary sphincterotomy
27. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices
28. Practice guidelines: Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension
29. Portal hypertension and variceal bleeding: An AASLD single topic symposium
30. The course of patients after variceal hemorrhage
31. Comparison of percutaneous endoscopic gastrostomy with Stamm gastrostomy
32. Percutaneous endoscopic gastrostomy: Initial placement by single endoscopic technique and long-term follow-up
33. Disorders of the vitamin K-dependent coagulation factors
34. Effect of intranasal oxygen on hypoxia and tachycardia during endoscopic cholangiopancreatography
35. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis
36. Arterial oxygen saturation during emergency esophagogastroduodenoscopy: The effects of nasal oxygen
37. Pulse oximetry and supplemental oxygen during gastrointestinal endoscopy: A critical review
38. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding
39. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: A meta-analysis
40. Flumazenil disposition and elimination in cirrhosis
41. Initial results of a randomized study of emergency banding vs. sclerotherapy for bleeding gastric or esophageal varices
42. Hemostasis abnormalities in liver disease
43. Management of upper gastrointestinal bleeding in the patient with chronic liver disease
44. Thromboelastography in liver transplantation
45. Use of a modified non-rebreathing mask during upper intestinal endoscopy
46. Alpha2-antiplasmin inhibitor metabolism in patients with liver cirrhosis
47. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analysis
48. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
49. Coagulation abnormalities in liver disease
50. Cardiopulmonary risk of esophagogastroduodenoscopy: Role of endoscope diameter and systemic sedation
51. Respiratory complications in critically ill medical patients with acute upper gastrointestinal bleeding
52. Pulmonary aspiration during emergency endoscopy in patients with upper gastrointestinal hemorrhage
53. A prospective, randomized trial of injection sclerotherapy vs. banding ligation in the management of bleeding esophageal varices
54. Pharmacokinetics and pharmacodynamics of intravenous midazolam patients with severe alcoholic cirrhosis
55. Coagulation defects in liver disease
56. Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time
57. Endoscopic variceal treatment, is band ligation taking over sclerotherapy?
58. Complications of upper gastrointestinal endoscopy and their management
59. A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver
60. Antimicrobial prophylaxis after gastrointestinal hemorrhage for cirrhotic patients with a high risk of infection
61. Prospective audit of upper gastrointestinal endoscopy in two regions of England: Safety, staffing, and sedation methods
62. Effects of sedation and supplemental oxygen during upper alimentary tract endoscopy
63. Complications of fiberoptic gastrointestinal endoscopy: Five years experience in a central hospital
64. Nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
65. Reduced histidine-rich glycoprotein levels in plasma of patients with advanced liver cirrhosis: Possible implications for enhanced fibrinolysis
66. Sclerosants for variceal sclerotherapy: A critical appraisal
67. Satisfactory outcome of percutaneous endoscopic gastrostomy in two patients with cirrhosis and portal hypertension
68. The national ASGE survey on upper gastrointestinal bleeding
69. Endoscopic complications: Results of the 1974 American Society for Gastrointestinal Endoscopy Survey
70. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
71. Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease
72. Results of experimental endoscopic esophageal varix ligation
73. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
74. Prospective randomized study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation
75. Pharmacokinetics of opioids in liver disease
76. Bacteremia after endoscopic band ligation of esophageal varices
77. Investigations on the fibrinolytic system in liver cirrhosis
78. Gastroenterological procedures among patients with disorders of hemostasis: Evaluation and management recommendations
79. Arterial desaturation during emergent nonsedated upper gastrointestinal endoscopy in the emergency department
80. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy